naltrexone has been researched along with Cholestasis in 32 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (15.63) | 18.2507 |
| 2000's | 19 (59.38) | 29.6817 |
| 2010's | 7 (21.88) | 24.3611 |
| 2020's | 1 (3.13) | 2.80 |
| Authors | Studies |
|---|---|
| Murray-Brown, FL | 1 |
| Abdollahzadeh Estakhri, MR; Dehpour, AR; Haj-Mirzaian, A; Hamzeh, N; Javadi-Paydar, M | 1 |
| Dehpour, AR; Ebadian, S; Ghiassy, B; Javadi-Paydar, M; Norouzi, A; Rahimi, N | 1 |
| Mittal, A | 1 |
| Alaeddini, M; Dehpour, AR; Doustimotlagh, AH; Etemad-Moghadam, S; Golestani, A; Kheirandish, Y | 1 |
| Dehpour, AR; Hormazdi, B; Kiani, S; Najafi, T; Samadi, H; Samini, M; Valizadeh, B | 1 |
| Asadi, S; Assa, S; Dehpour, AR; Emami, H; Nezami, BG; Rasouli, MR; Talab, SS; Tavangar, SM | 1 |
| Dehpour, AR; Deroee, AF; Hosseini, R; Jahanzad, I; Mehr, SE; Nezami, BG; Salmasi, AH; Talab, SS | 1 |
| Roy, A; Schwarz, KB; Zellos, A | 1 |
| Bailey, A; Garg, N; Kumar, N | 1 |
| Dehpour, AR; Nilforoushan, D; Shirazi, M | 1 |
| Coronel, E; Findor, J; Muñoz, AE; Sordá, J; Terg, R | 1 |
| Ahmadi, H; Dehpour, AR; Ejtemaei-Mehr, S; Gaskari, SA; Homayoun, H; Mani, AR; Namiranian, K | 1 |
| Dehpour, AR; Demehri, S; Gaskari, SA; Mehr, SE; Namiranian, K; Rastegar, H; Roushanzamir, F; Shariftabrizi, A | 1 |
| Borhani, AA; Dehghani, M; Dehpour, AR; Hajrasouliha, AR; Houshmand, G; Jabehdar-Maralani, P; Sadeghipour, H; Shafaroodi, H; Tavakoli, S | 1 |
| Blum, HE; Kreisel, W; Opitz, OG; Thimme, R | 1 |
| Borhani, AA; Dehpour, AR; Ebrahimi, F; Hajrasouliha, AR; Houshmand, G; Namiranian, K; Samini, M; Tavakoli, S | 1 |
| Ahmadi, SH; Borhani, AA; Dehpour, AR; Ebrahimi, F; Hajrasouliha, AR; Houshmand, G; Riazi, K; Sadeghipour, H; Shafaroodi, H; Tavakoli, S | 1 |
| Bagherzadeh, AH; Ebrahimi-Dariani, N; Farahvash, MJ; Farhangi, E; Froutan, H; Ghofrani, H; Mansour-Ghanaei, F; Mirmomen, S; Nasiri-Toosi, M; Pourrasouli, Z; Taheri, A | 1 |
| Dehghani, M; Dehpour, AR; Ebrahimi, F; Hajrasouliha, AR; Jabehdar-Maralani, P; Sadeghipour, H; Shafaroodi, H; Tavakoli, S | 1 |
| Anvari, P; Dehpour, AR; Kiumehr, S; Nezami, BG; Payabvash, S; Tavangar, SM; Zandieh, A | 1 |
| Dehpour, AR; Ghasemi, M; Shafaroodi, H | 1 |
| Dehpour, AR; Doratotaj, B; Gholipour, T; Honar, H; Jannati, A; Nik, HH; Noorian, AR; Riazi, K; Shariftabrizi, A | 1 |
| Jourd'Heuil, D; Lang, ME; Meddings, JB; Swain, MG | 1 |
| Bertolotti, M; Hop, WC; Sternieri, E; Van Buuren, HR; Vitale, G; Wolfhagen, FH | 1 |
| Alling, DW; Bergasa, NV; Jenkins, JB; Jones, EA; Schmitt, JM; Swain, MG; Talbot, TL; Turner, ML | 1 |
| Sapey, T | 1 |
| Alling, DW; Bergasa, NV; Jones, EA; Talbot, TL; Wells, MC | 1 |
| Dekker, LR; Jones, EA | 1 |
| Dehpour, AR; Gaskari, SA; Homayoun, H; Mehr, SE; Namiranian, K; Rastegar, H; Samini, M | 1 |
| Akbari, MR; Dehpour, AR; Homayounfar, H; Mani, AR; Nahavandi, A | 1 |
| Dehpour, AR; Homayoun, H; Sayyah, M | 1 |
3 review(s) available for naltrexone and Cholestasis
| Article | Year |
|---|---|
Naltrexone for cholestatic itch: a systematic review.
Topics: Adult; Aged; Aged, 80 and over; Analgesics; Cholestasis; End Stage Liver Disease; Female; Humans; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Pain; Pilot Projects; Pruritus; Research Design; Retrospective Studies | 2021 |
Cholestatic Itch Management.
Topics: Anion Exchange Resins; Cholagogues and Choleretics; Cholestasis; Cholestyramine Resin; Humans; Lysophospholipids; Naltrexone; Narcotic Antagonists; Plasmapheresis; Pregnane X Receptor; Pruritus; Receptors, Steroid; Rifampin; Selective Serotonin Reuptake Inhibitors; Sertraline; Ultraviolet Therapy; Ursodeoxycholic Acid | 2016 |
[Cholestatic liver diseases].
Topics: Anti-Bacterial Agents; Antibodies, Antineutrophil Cytoplasmic; Anticholesteremic Agents; Antipruritics; Autoimmune Diseases; Bile Ducts; Cholagogues and Choleretics; Cholangiography; Cholangitis; Cholangitis, Sclerosing; Cholestasis; Cholestyramine Resin; Clinical Enzyme Tests; Diagnosis, Differential; Hepatitis, Autoimmune; Humans; Immunosuppression Therapy; Inflammatory Bowel Diseases; Liver Cirrhosis; Liver Cirrhosis, Biliary; Liver Transplantation; Naloxone; Naltrexone; Narcotic Antagonists; Ondansetron; Plasmapheresis; Ursodeoxycholic Acid | 2004 |
6 trial(s) available for naltrexone and Cholestasis
| Article | Year |
|---|---|
Nitric oxide mediates the beneficial effect of chronic naltrexone on cholestasis-induced memory impairment in male rats.
Topics: Animals; Cholestasis; Disease Models, Animal; Drug Administration Schedule; Enzyme Inhibitors; Guanidines; Ligation; Male; Maze Learning; Memory Disorders; Naltrexone; Narcotic Antagonists; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Wistar; Space Perception; Time Factors | 2013 |
Efficacy and safety of oral naltrexone treatment for pruritus of cholestasis, a crossover, double blind, placebo-controlled study.
Topics: Administration, Oral; Adult; Aged; Cholestasis; Cross-Over Studies; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Pain Measurement; Pruritus; Safety | 2002 |
Effect of oral naltrexone on pruritus in cholestatic patients.
Topics: Administration, Oral; Adult; Aged; Cholestasis; Dizziness; Headache; Humans; Middle Aged; Muscle Weakness; Naltrexone; Nausea; Pain Measurement; Placebos; Pruritus; Single-Blind Method; Substance Withdrawal Syndrome; Surveys and Questionnaires | 2006 |
Oral naltrexone treatment for cholestatic pruritus: a double-blind, placebo-controlled study.
Topics: Administration, Oral; Adult; Aged; Cholangitis, Sclerosing; Cholestasis; Double-Blind Method; Fatigue; Female; Humans; Liver Cirrhosis, Biliary; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Placebos; Pruritus | 1997 |
Open-label trial of oral nalmefene therapy for the pruritus of cholestasis.
Topics: Administration, Oral; Adolescent; Adult; Aged; Child; Cholestasis; Humans; Middle Aged; Naltrexone; Narcotic Antagonists; Pruritus | 1998 |
Oral nalmefene therapy reduces scratching activity due to the pruritus of cholestasis: a controlled study.
Topics: Administration, Oral; Adult; Antipruritics; Cholestasis; Double-Blind Method; Humans; Naltrexone; Narcotic Antagonists; Pain Measurement; Pruritus; Tablets; Time Factors | 1999 |
23 other study(ies) available for naltrexone and Cholestasis
| Article | Year |
|---|---|
Resistance to depression through interference of opioid and nitrergic systems in bile-duct ligated mice.
Topics: Animals; Bile Ducts; Cholestasis; Depression; Enzyme Inhibitors; Ligation; Male; Mice; Motor Activity; Naltrexone; Narcotic Antagonists; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Swimming | 2013 |
Nitrergic and opioidergic systems affect radiographic density and histomorphometric indices in bile-duct-ligated cirrhotic rats.
Topics: Animals; Bile Ducts; Bilirubin; Bone and Bones; Cholestasis; Enzyme Inhibitors; Ligation; Liver; Liver Cirrhosis, Biliary; Male; Naltrexone; Narcotic Antagonists; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Rats; Rats, Sprague-Dawley; Receptors, Opioid; Skull | 2017 |
Alteration in male reproductive system in experimental cholestasis: roles for opioids and nitric oxide overproduction.
Topics: Animals; Bile Ducts; Cholestasis; Disease Models, Animal; Dose-Response Relationship, Drug; Follicle Stimulating Hormone; Genitalia, Male; Ligation; Luteinizing Hormone; Male; Naltrexone; Narcotic Antagonists; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Opioid Peptides; Rats; Rats, Sprague-Dawley; Sperm Count; Sperm Motility; Testosterone | 2009 |
Chronic upregulation of the endogenous opioid system impairs the skin flap survival in rats.
Topics: Animals; Cholestasis; Male; Naltrexone; Narcotic Antagonists; Oxidative Stress; Rats; Rats, Sprague-Dawley; Skin; Surgical Flaps; Wound Healing | 2009 |
Cholestasis induced nephrotoxicity: the role of endogenous opioids.
Topics: Acetylglucosaminidase; Analgesics, Opioid; Animals; Bilirubin; Cholestasis; Enzyme Activation; Kidney; Kidney Diseases; Liver; Male; Naltrexone; Narcotic Antagonists; Rats; Rats, Sprague-Dawley | 2010 |
Use of oral naltrexone for severe pruritus due to cholestatic liver disease in children.
Topics: Administration, Oral; Adolescent; Alagille Syndrome; Antipruritics; Child; Child, Preschool; Cholangitis, Sclerosing; Cholestasis; Female; Humans; Naltrexone; Pruritus | 2010 |
Opiate receptor antagonists for treatment of severe pruritus associated with advanced cholestatic liver disease.
Topics: Aged, 80 and over; Cholestasis; Comorbidity; Humans; Male; Naloxone; Naltrexone; Narcotic Antagonists; Pruritus; Quality of Life; Quaternary Ammonium Compounds | 2013 |
The role of opioid systems on orthodontic tooth movement in cholestatic rats.
Topics: Analysis of Variance; Animals; Bile Ducts; Bone Remodeling; Cholestasis; Dental Alloys; Disease Models, Animal; Injections, Subcutaneous; Male; Naltrexone; Narcotic Antagonists; Nickel; Opioid Peptides; Orthodontic Wires; Random Allocation; Rats; Rats, Sprague-Dawley; Statistics as Topic; Stress, Mechanical; Titanium; Tooth Movement Techniques; Treatment Outcome | 2002 |
Do endogenous opioids contribute to the bradycardia of rats with obstructive cholestasis?
Topics: Alanine Transaminase; Alkaline Phosphatase; Animals; Arginine; Bradycardia; Cholestasis; Dose-Response Relationship, Drug; Electrocardiography; Epinephrine; Guanidines; Heart Atria; Heart Rate; In Vitro Techniques; Male; Naltrexone; Narcotic Antagonists; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Opioid Peptides; Rats; Rats, Sprague-Dawley; Tyrosine | 2002 |
Alpha-2-adrenoceptor hyporesponsiveness in isolated tissues of cholestatic animals: involvement of opioid and nitric oxide systems.
Topics: Animals; Catecholamines; Cholestasis; Clonidine; Dose-Response Relationship, Drug; Guinea Pigs; Male; Mice; Naltrexone; Nitric Oxide; Receptors, Adrenergic, alpha-2; Receptors, Opioid; Yohimbine | 2003 |
Resistance of cholestatic rats against epinephrine-induced arrhythmia: the role of nitric oxide and endogenous opioids.
Topics: Animals; Arrhythmias, Cardiac; Blood Pressure; Cholestasis; Enzyme Inhibitors; Epinephrine; Heart Rate; Injections, Intravenous; Male; Naltrexone; Narcotic Antagonists; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Rats; Rats, Sprague-Dawley | 2004 |
alpha2-Adrenoceptor subsensitivity in mesenteric vascular bed of cholestatic rats: the role of nitric oxide and endogenous opioids.
Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Bilirubin; Cholestasis; Clonidine; Dose-Response Relationship, Drug; Enzyme Inhibitors; Guanidines; Male; Mesenteric Arteries; Mesentery; Naltrexone; Narcotic Antagonists; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitroprusside; Opioid Peptides; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2; Vasodilation; Vasodilator Agents; Yohimbine | 2005 |
Contribution of endogenous opioids and nitric oxide to papillary muscle contractile impairment in cholestatic rats.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Analysis of Variance; Animals; Bile Ducts; Cardiomyopathies; Cholestasis; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Isoproterenol; Ligation; Male; Myocardial Contraction; Naltrexone; Narcotic Antagonists; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Opioid Peptides; Papillary Muscles; Phenylephrine; Rats; Rats, Sprague-Dawley | 2005 |
Modulated hemodynamic response to clonidine in bile duct-ligated rats: the role of nitric oxide.
Topics: Animals; Antihypertensive Agents; Bile Ducts; Blood Pressure; Bradycardia; Cholestasis; Clonidine; Dose-Response Relationship, Drug; Enzyme Inhibitors; Heart Rate; Injections, Intravenous; Injections, Subcutaneous; Ligation; Male; Naltrexone; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Rats; Rats, Sprague-Dawley | 2006 |
Endogenous opioids modulate hepatocyte apoptosis in a rat model of chronic cholestasis: the role of oxidative stress.
Topics: Analgesics, Opioid; Animals; Apoptosis; Biological Factors; Cholestasis; Chronic Disease; Disease Models, Animal; Dose-Response Relationship, Drug; Hepatocytes; Liver; Naltrexone; Narcotic Antagonists; Oxidative Stress; Rats | 2007 |
Elevation of pentylenetetrazole-induced seizure threshold in cholestatic mice: interaction between opioid and cannabinoid systems.
Topics: Animals; Anticonvulsants; Bile Ducts; Cannabinoid Receptor Modulators; Cholestasis; Disease Models, Animal; Dose-Response Relationship, Drug; Ligation; Male; Mice; Naltrexone; Narcotic Antagonists; Opioid Peptides; Pentylenetetrazole; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Receptors, Opioid; Seizures; Time Factors | 2008 |
Seizure susceptibility alteration following reversible cholestasis in mice: Modulation by opioids and nitric oxide.
Topics: 1-Naphthylisothiocyanate; Alkaline Phosphatase; Animals; Bilirubin; Biomarkers; Cholestasis; Corn Oil; Disease Models, Animal; Disease Susceptibility; Dose-Response Relationship, Drug; Infusions, Intravenous; Intubation, Gastrointestinal; Male; Mice; Morphine; Naltrexone; Narcotic Antagonists; NG-Nitroarginine Methyl Ester; Nitric Oxide; Pentylenetetrazole; Receptors, Opioid; Seizures; Time Factors | 2008 |
Increased opioid binding to peripheral white blood cells in a rat model of acute cholestasis.
Topics: Acute Disease; Animals; Cholestasis; Disease Models, Animal; Enkephalins; Flow Cytometry; Leukocytes; Lymphocytes; Male; Monocytes; Naltrexone; Neutrophils; Rats; Rats, Sprague-Dawley; Receptors, Opioid; Receptors, Opioid, delta; Receptors, Opioid, mu | 1995 |
[Opiod antagonists and treatment of cholestatic pruritus].
Topics: Cholestasis; Double-Blind Method; Humans; Naltrexone; Narcotic Antagonists; Placebos; Pruritus; Randomized Controlled Trials as Topic | 1998 |
Florid opioid withdrawal-like reaction precipitated by naltrexone in a patient with chronic cholestasis.
Topics: Administration, Oral; Adult; Cholestasis; Chronic Disease; Female; Humans; Infusions, Intravenous; Naltrexone; Narcotic Antagonists; Pruritus; Substance Withdrawal Syndrome | 2000 |
Mesenteric vascular bed responsiveness in bile duct-ligated rats: roles of opioid and nitric oxide systems.
Topics: Acetylcholine; Animals; Bile Ducts; Cholestasis; Dose-Response Relationship, Drug; Enzyme Inhibitors; Ligation; Male; Mesenteric Arteries; Naltrexone; Narcotic Antagonists; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitroprusside; Opioid Peptides; Phenylephrine; Rats; Rats, Sprague-Dawley; Vascular Resistance; Vasoconstriction; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents | 2001 |
The role of the interaction between endogenous opioids and nitric oxide in the pathophysiology of ethanol-induced gastric damage in cholestatic rats.
Topics: Alcohol Deterrents; Animals; Arginine; Bile Ducts; Cholestasis; Disease Models, Animal; Enzyme Inhibitors; Ethanol; Gastric Mucosa; Ligation; Male; Naltrexone; Narcotic Antagonists; NG-Nitroarginine Methyl Ester; Nitrates; Nitric Oxide; Nitrites; Opioid Peptides; Rats; Stomach Ulcer | 2001 |
The additive effect of opioids and nitric oxide in increasing pentylenetetrazole-induced seizure threshold in cholestatic mice.
Topics: Animals; Cholestasis; Convulsants; Disease Models, Animal; Dose-Response Relationship, Drug; Male; Mice; Naltrexone; NG-Nitroarginine Methyl Ester; Nitric Oxide; Pentylenetetrazole; Seizures | 2002 |